Glenmark Life Sciences Limited (GLS.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Glenmark Life Sciences Limited
Address
Glenmark House
Mumbai, 400099
India
Phone
91 21 8923 4456
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2014
First IPO Date
August 06, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Yasir Yusufali Rawjee | Chief Executive Officer, MD & Director | 272.35M | 1965 |
| Sumantra Mitra | Senior Vice President & Head of Human Resources | 18.2M | N/A |
| Vinod Naik | Group Vice President, Head of Technical Operations & Whole Time Director | 56.56M | N/A |
| Mathew George | Senior Vice President & Head of Regulatory Affairs | 0 | N/A |
| Rudalf Corriea | Company Secretary & Compliance Officer | 0 | N/A |
| Tushar Mistry | Senior Vice President & Chief Financial Officer | 0 | N/A |
| Soumi Rao | General Manager of Corporate Communications | 0 | N/A |
| Navin Kumar Agrawal | Vice President & Head of Corporate Quality | 0 | N/A |
Description
Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011, specializes in the creation, manufacturing, and distribution of high-value active pharmaceutical ingredients (APIs). These APIs are utilized across a wide array of chronic therapeutic areas. The company's diverse portfolio includes compounds for managing cardiovascular diseases (e.g., Olmesartan, Rosuvastatin, Amiodarone), central nervous system conditions (such as Oxcarbazepine, Topiramate, Lacosamide), and diabetes (including Glimepiride, Teneligliptin, Linagliptin). Additionally, they produce APIs for pain management (Etoricoxib, Lornoxicam), gastro-intestinal disorders, anti-infective treatments, respiratory ailments, and anti-emetic applications, featuring products like Atovaquone, Fluconazole, and Esomeprazole Magnesium. Beyond API production, Glenmark Life Sciences offers contract development and manufacturing (CDMO) solutions to numerous multinational and specialty pharmaceutical firms. Operating as a subsidiary of Glenmark Pharmaceuticals Limited, the company exports its products worldwide, reaching markets in Europe, North America, Latin America, and Japan.
